Neoadjuvant intralesional daromun (L19IL2/L19TNF) improves outcomes in resectable, relapsed, locally advanced melanoma regardless of prior therapy: subgroup analyses from the randomized phase 3 trial PIVOTAL

Samankaltaisia teoksia

• Neoadjuvant intralesional daromun (L19IL2/L19TNF) improves outcomes in resectable, relapsed, locally advanced melanoma regardless of prior therapy: subgroup analyses from the randomized phase 3 trial PIVOTAL
  Tekijä: J.C. Hassel, et al.
  Julkaistu: (2026-01-01)
• Line-field confocal optical coherence tomography for monitoring intralesional immunotherapy with L19IL2/L19TNF (daromun) in recurrent basal cell carcinoma
  Tekijä: M.F. Vera Morandini, et al.
  Julkaistu: (2026-01-01)
• Effective treatment of aggressive cSCC originating from a chronic ulcer
  Tekijä: U. Gerbutaviciene, et al.
  Julkaistu: (2026-01-01)
• Duncan Dancer
  Julkaistu: (1966)
• Joseph Duncan Putnam
  Tekijä: Benjamin Pickman Mann
  Julkaistu: (1882-01-01)